Northern Michigan Neurology

Traverse City, Michigan 49684

0 studies enrolling now · 13 studies all time

What they study most

Acute Ischemic Stroke, Alzheimer's Disease, Cognition Disorders, Dementia, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Orthostatic Hypotension, Parkinson Disease, Off Episodes, Parkinson's Disease, Symptomatic Neurogenic Orthostatic Hypotension

Studies at this site

• Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension — Completed
• Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease — Completed
• IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis — Completed
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
• A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy — Completed
• An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed
• A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease — Completed
• Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease — Completed
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed
• Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed
• A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis — Completed
• A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) — Completed